These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27058907)

  • 1. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
    Tsuyuki RT; Al Hamarneh YN; Jones CA; Hemmelgarn BR
    J Am Coll Cardiol; 2016 Jun; 67(24):2846-54. PubMed ID: 27058907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled R
    Al Hamarneh YN; Tsuyuki RT; Jones CA; Manns B; Tonelli M; Scott-Douglass N; Jindal K; Tink W; Hemmelgarn BR
    Am J Kidney Dis; 2018 Jan; 71(1):42-51. PubMed ID: 28912054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R
    Al Hamarneh YN; Hemmelgarn BR; Hassan I; Jones CA; Tsuyuki RT
    Can J Diabetes; 2017 Dec; 41(6):580-586. PubMed ID: 28965748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.
    Amariles P; Sabater-Hernández D; García-Jiménez E; Rodríguez-Chamorro MÁ; Prats-Más R; Marín-Magán F; Galán-Ceballos JA; Jiménez-Martín J; Faus MJ
    J Manag Care Pharm; 2012 May; 18(4):311-23. PubMed ID: 22548691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R
    Al Hamarneh YN; Marra C; Gniadecki R; Keeling S; Morgan A; Tsuyuki R
    BMJ Open; 2021 Mar; 11(3):e043612. PubMed ID: 33762234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worksite-based cardiovascular risk screening and management: a feasibility study.
    Padwal R; Rashead M; Snider J; Morrin L; Lehman A; Campbell NR
    Vasc Health Risk Manag; 2017; 13():209-213. PubMed ID: 28652760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
    Santschi V; Chiolero A; Burnand B; Colosimo AL; Paradis G
    Arch Intern Med; 2011 Sep; 171(16):1441-53. PubMed ID: 21911628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacist-provided extended diabetes care.
    Doucette WR; Witry MJ; Farris KB; McDonough RP
    Ann Pharmacother; 2009 May; 43(5):882-9. PubMed ID: 19401477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (R
    Tam-Tham H; Clement F; Hemmelgarn BR; Manns BJ; Klarenbach SW; Tonelli M; Tsuyuki RT; Al Hamarneh YN; Penko J; Weaver CGW; Au F; Weaver RG; Jones CA; McBrien KA
    Value Health; 2019 Oct; 22(10):1128-1136. PubMed ID: 31563255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).
    Tsuyuki RT; Houle SK; Charrois TL; Kolber MR; Rosenthal MM; Lewanczuk R; Campbell NR; Cooney D; McAlister FA;
    Circulation; 2015 Jul; 132(2):93-100. PubMed ID: 26063762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
    Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
    Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study.
    Villeneuve J; Genest J; Blais L; Vanier MC; Lamarre D; Fredette M; Lussier MT; Perreault S; Hudon E; Berbiche D; Lalonde L
    CMAJ; 2010 Mar; 182(5):447-55. PubMed ID: 20212029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle changes for prehypertension with other cardiovascular risk factors: findings from Thailand.
    Pongwecharak J; Treeranurat T
    J Am Pharm Assoc (2003); 2011; 51(6):719-26. PubMed ID: 22068193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BC Clinical impact of medication reviews with follow-up in cardiovascular older patients in primary care: A cluster-randomized controlled trial.
    Martínez-Mardones F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; Garcia-Cardenas V
    Br J Clin Pharmacol; 2023 Jul; 89(7):2131-2143. PubMed ID: 36735853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.